Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Precision biosciences, inc. symbols : Lly save search
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.9 -0.26% 320K
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | News | $13.735 -1.82% 1.2M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published: 2024-01-12 (Crawled : 22:00) - prnewswire.com
TGTX | News | $13.735 -1.82% 1.2M
|
Health Technology
| Email alert
Add to watchlist
VRTX | News | $395.42 0.49% 290K
|
Health Technology
| Email alert
Add to watchlist
RARE F | $43.45 0.16% 67K
|
Health Technology
| Email alert
Add to watchlist
SLDB | $9.05 -2.27% 27K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
| Email alert
Add to watchlist
LLY | $728.765 -2.3% 1.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BLUE | $0.9601 0.75% 1.9M
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.815 1.35% 410K
|
Health Technology
| Email alert
Add to watchlist
DTIL | $10.465 -2.38% 33K
|
Health Technology
| Email alert
Add to watchlist
global therapy market
Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: 0.0%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: 1.43%
H: 3.28%
C: 0.17%
congress cell arcus preclinical therapy
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-04 (Crawled : 12:20) - precisionbiosciences.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.38%
H: 0.73%
C: 0.15%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -0.95%
H: 0.0%
C: 0.0%
business update financial results
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-09 (Crawled : 12:00) - precisionbiosciences.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.35%
H: 1.06%
C: 0.48%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.38%
H: 0.39%
C: 0.18%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.22%
H: 0.89%
C: -0.79%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -2.94%
H: 5.45%
C: 3.03%
business update financial results
Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 4.44%
H: 1.53%
C: 0.43%
RIGL | $1.055 0.48% 260K
|
Health Technology
|
| O: -1.38%
H: 0.2%
C: -2.39%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -0.47%
H: 0.95%
C: -0.95%
results
Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential
Published: 2021-10-26 (Crawled : 11:00) - biospace.com/
ABCL | $3.85 -1.54% 380K
|
|
| O: -1.7%
H: 0.0%
C: 0.0%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
RIGL | $1.055 0.48% 260K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
PRQR | $1.98 6.45% 62K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
MRUS | $40.04 -1.06% 230K
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
financial results potential results growth
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ABCL | $3.85 -1.54% 380K
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
RIGL | $1.055 0.48% 260K
|
Health Technology
|
| O: 0.5%
H: 0.5%
C: -6.44%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -1.21%
MRUS | $40.04 -1.06% 230K
|
Health Technology
|
| O: 0.9%
H: 1.45%
C: 0.67%
financial results results liver
Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
Published: 2021-04-27 (Crawled : 12:00) - biospace.com/
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -0.03%
H: 0.26%
C: -0.11%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -1.72%
H: 1.02%
C: -0.97%
VIR | $7.87 -1.13% 220K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -3.69%
RIGL | $1.055 0.48% 260K
|
Health Technology
|
| O: 1.54%
H: 0.25%
C: -3.28%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: 0.4%
H: 3.33%
C: -1.11%
MRUS | $40.04 -1.06% 230K
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: -2.8%
financial results results liver
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
Published: 2021-03-18 (Crawled : 12:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.38%
H: 0.58%
C: -1.12%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: -3.64%
H: 4.41%
C: -4.14%
financial results results bioscience
Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
Published: 2021-01-07 (Crawled : 12:03) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.09%
H: 1.79%
C: 1.0%
DTIL | $10.465 -2.38% 33K
|
Health Technology
|
| O: 1.93%
H: 7.11%
C: 6.89%
collaboration license arcus
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.